Tous Actualités
Suivre
Abonner W.O.M. World of Medicine AG

W.O.M. World of Medicine AG

Second Quarter sales surpass 2006 levels by 18.7%

Ludwigsstadt (euro adhoc) -

  ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for
  the content of this announcement.
balance/Half-year Report
An increase in sales of 18.7% over the
second quarter of 2006, and 7.5% growth in mid-year sales to 
TE16,174: These are the extremely impressive results of the first six
months of fiscal year 2007 for listed medical device manufacturer 
WORLD OF MEDICINE. Earnings before taxes (EBT) from continued 
operations rose in the first half-year by almost E2.0 million, to 
TE2,414, when compared with the same period last year. The 
corresponding pre- tax sales yield equaled 14.9% (same period last 
year: 3.0%). "The second quarter developed far better than expected,"
said Peter P. Wiest, CEO of WORLD OF MEDICINE. "In addition to 
existing business operations, sales of the new generation of pumps 
contributed to the excellent performance. By the end of June, more 
than twice as many devices had been sold as in the same period last 
year."
|                   |HY1/2007           |HY1/2006           |Change
|
|Sales              |TE16,174           |TE15,048           |+ 7.5 %
|
|EBT                |TE2,414            |TE459              |+TE1,955
|
|Sales yield        |14.9%              |3.0%               |> 100%
|
|Earnings per share |E0.27              |E0.03              |> 100%
|
Moreover, income not included in the 2007 budget was received in the 
form of payments from former subsidiary IB Laser AG. WORLD OF 
MEDICINE is now reviewing the use of these funds for the advancement 
of development projects scheduled for 2008. "This may place a strain 
on consolidated net income in the second half-year, as will the 
corporate tax reform passed by the German Bundesrat. For this reason,
the after-tax yield of 15.0% shown at half-year cannot be projected 
on a linear basis across the year as a whole," states Peter P. Wiest.
"However, we see clear indications that the momentum for growth will 
continue unabated: The volume of orders at the end of June reached 
its highest level for the year, and is now 57.4% ahead of that same 
figure at last year's reporting date. Sales development in July was 
extremely impressive, and production is more than fully utilized."
The Management Board therefore stands behind its projection of a 10% 
pre-tax sales yield for the year 2007.
The full half-year report is available at
www.world-of-medicine.com/wsc/q2-2007-en.pdf
WORLD OF MEDICINE and its technologies are paving the way in 
Minimally Invasive Surgery - or MIS( for short. This approach 
includes safe and gentle surgical procedures conducted not through 
major incisions, but through keyhole or puncture incisions. The 
Company is the global market leader in a niche of this future market.
Today at 2:00 pm CET, a telephone conference on the quarterly figures
is scheduled for analysts, investors and press representatives. To 
participate, please contact WORLD OF MEDICINE directly.
end of announcement                               euro adhoc 09.08.2007 08:00:00

Further inquiry note:

Stefanie Gehrke
Tel.: +49 (0)30 39981 566
E-Mail: stefanie.gehrke@womcorp.com

Branche: Pharmaceuticals
ISIN: DE0006637390
WKN: 663739
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Hamburg / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse München / free trade

Plus de actualités: W.O.M. World of Medicine AG
Plus de actualités: W.O.M. World of Medicine AG